Public research preview
Christopher L. Jacobs, Representative disclosure: Kura Oncology, Inc. (KURA)
Disclosed a buy transaction in Kura Oncology, Inc. (KURA). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 20 Jan 2023, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 39 days
Tidslinje
Transaktionsdato
12 Dec 2022
Offentliggørelse
20 Jan 2023
Nu
Sporet i dag
Indberetningsforsinkelse: 39 dage
Kursbevægelse
Komplet dækning
- Udbyder
- Yahoo Finance daily close
- Hentet
- 9. sep. 2026
Kursforløb
KURA fra kontekst før transaktionen til seneste lukkekurs.
Købt
12. dec. 2022 · 13,17 USD · Endnu ikke offentlig
Systemets beslutning
Ville ikke købe — Strategiens filtre afviser dette signal. Fejlede filtre: Filed within 30 days.
- Endnu ikke offentlig
- Ville ikke købe
- Observeret luk ved transaktion
- 13,17
- Observeret luk ved offentliggørelse
- 13,93
- Observeret seneste luk
- 12,52
- Bevægelse før indberetning
- +5,8 %
- Bevægelse efter indberetning
- -10,1 %
- Markedsjusteret bevægelse
- -32,5 %
- 1w since disclosure
- -2,1 %
- 1m since disclosure
- -15,1 %
- 3m since disclosure
- -22,7 %
- Topstigning før indberetning
- +8,6 %
- Tilbagetrækning fra top
- -2,6 %
Why Copy Window is Probably too late
Supporting factors
- Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 20 Jan 2023, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%